Literature DB >> 3029424

Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha.

C Upton, J L Macen, G McFadden.   

Abstract

Myxoma virus, a Leporipoxvirus and agent of myxomatosis, was shown to possess a gene with the potential to encode an epidermal growth factorlike factor. Its relationship to other members of this family, including the poxvirus growth factors from Shope fibroma virus and vaccinia virus, was analyzed. Alignment of DNA sequences and related open reading frames of myxoma virus and Shope fibroma virus indicated colinearity of genes between these poxviruses.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3029424      PMCID： PMC254093          DOI： 10.1128/JVI.61.4.1271-1275.1987

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  20 in total

1.  The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha.

Authors:  W Chang; C Upton; S L Hu; A F Purchio; G McFadden
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.

Authors:  S Henikoff
Journal:  Gene       Date:  1984-06       Impact factor: 3.688

3.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

4.  Tumorigenic poxviruses: construction of the composite physical map of the Shope fibroma virus genome.

Authors:  A M Delange; C Macaulay; W Block; T Mueller; G McFadden
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  Physical characterization and molecular cloning of the Shope fibroma virus DNA genome.

Authors:  A Wills; A M Delange; C Gregson; C Macaulay; G McFadden
Journal:  Virology       Date:  1983-10-30       Impact factor: 3.616

6.  The Florey lecture, 1983. Biological control, as exemplified by smallpox eradication and myxomatosis.

Authors:  F Fenner
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-06-22

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors.

Authors:  M C Blomquist; L T Hunt; W C Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Immunohistology of malignant rabbit fibroma virus--a comparative study with rabbit myxoma virus.

Authors:  D S Strayer; S Sell
Journal:  J Natl Cancer Inst       Date:  1983-07       Impact factor: 13.506

10.  Malignant rabbit fibroma virus: observations on the culture and histopathologic characteristics of a new virus-induced rabbit tumor.

Authors:  D S Strayer; G Cabirac; S Sell; J L Leibowitz
Journal:  J Natl Cancer Inst       Date:  1983-07       Impact factor: 13.506
View more
  24 in total

1.  Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.

Authors:  E Tzahar; J D Moyer; H Waterman; E G Barbacci; J Bao; G Levkowitz; M Shelly; S Strano; R Pinkas-Kramarski; J H Pierce; G C Andrews; Y Yarden
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

2.  Characterization of vaccinia virus growth factor biosynthetic pathway with an antipeptide antiserum.

Authors:  W Chang; J G Lim; I Hellström; L E Gentry
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Transforming growth factor alpha: an aromatic side chain at position 38 is essential for biological activity.

Authors:  E Lazar; E Vicenzi; E Van Obberghen-Schilling; B Wolff; S Dalton; S Watanabe; M B Sporn
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

4.  Identification by a random sequencing strategy of the fowlpoxvirus DNA polymerase gene, its nucleotide sequence and comparison with other viral DNA polymerases.

Authors:  M M Binns; L Stenzler; F M Tomley; J Campbell; M E Boursnell
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

5.  Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein.

Authors:  S Bertagnoli; J Gelfi; G Le Gall; E Boilletot; J F Vautherot; D Rasschaert; S Laurent; F Petit; C Boucraut-Baralon; A Milon
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.

Authors:  F Messud-Petit; J Gelfi; M Delverdier; M F Amardeilh; R Py; G Sutter; S Bertagnoli
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 7.  Potential role of the epidermal growth factor receptor in human pancreatic cancer.

Authors:  M Korc
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

8.  The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor.

Authors:  A E Tollefson; A R Stewart; S P Yei; S K Saha; W S Wold
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 9.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

10.  M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit.

Authors:  Sophie Blanié; Jérémy Mortier; Maxence Delverdier; Stéphane Bertagnoli; Christelle Camus-Bouclainville
Journal:  Vet Res       Date:  2008-11-19       Impact factor: 3.683
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.